Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diane-35 versus drospirenone/ethinylestradiol tablets in polycystic ovary syndrome
ChiCTR1900021593Phase 4Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in polycystic ovary syndrome (PCOS) comparing Diane-35 with Drospirenone and Ethinylestradiol Tablets (II) (2 arms). Primary endpoints: Clinical symptoms of hyperandrogenemia, Biochemical indicators of hyperandrogenemia and 1 more. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
ethinyl estradiol + cyproteroneethinyl estradiol + drospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR1900021593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021593.